UniProt ID | P63_HUMAN | |
---|---|---|
UniProt AC | Q9H3D4 | |
Protein Name | Tumor protein 63 | |
Gene Name | TP63 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 680 | |
Subcellular Localization | Nucleus . | |
Protein Description | Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter.. | |
Protein Sequence | MNFETSRCATLQYCPDPYIQRFVETPAHFSWKESYYRSTMSQSTQTNEFLSPEVFQHIWDFLEQPICSVQPIDLNFVDEPSEDGATNKIEISMDCIRMQDSDLSDPMWPQYTNLGLLNSMDQQIQNGSSSTSPYNTDHAQNSVTAPSPYAQPSSTFDALSPSPAIPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQQVSDSTKNGDGTKRPFRQNTHGIQMTSIKKRRSPDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQQHQHLLQKQTSIQSPSSYGNSSPPLNKMNSMNKLPSVSQLINPQQRNALTPTTIPDGMGANIPMMGTHMPMAGDMNGLSPTQALPPPLSMPSTSHCTPPPPYPTDCSIVSFLARLGCSSCLDYFTTQGLTTIYQIEHYSMDDLASLKIPEQFRHAIWKGILDHRQLHEFSSPSHLLRTPSSASTVSVGSSETRGERVIDAVRFTLRQTISFPPRDEWNDFNFDMDARRNKQQRIKEEGE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 (in isoform 10) | Phosphorylation | - | 20.30 | 24043423 | |
13 | Phosphorylation | SRCATLQYCPDPYIQ CCCEECCCCCCHHHH | 14.73 | 22817900 | |
13 (in isoform 10) | Phosphorylation | - | 14.73 | 24043423 | |
15 (in isoform 10) | Phosphorylation | - | 40.45 | 24043423 | |
16 (in isoform 10) | Phosphorylation | - | 45.10 | 24043423 | |
17 (in isoform 10) | Phosphorylation | - | 17.17 | 24043423 | |
18 | Phosphorylation | LQYCPDPYIQRFVET CCCCCCHHHHHHHCC | 19.64 | 22817900 | |
30 | Phosphorylation | VETPAHFSWKESYYR HCCCCCCCHHHHHHH | 27.63 | 27067055 | |
36 | Phosphorylation | FSWKESYYRSTMSQS CCHHHHHHHHCCCCC | 13.84 | 22817900 | |
43 | Phosphorylation | YRSTMSQSTQTNEFL HHHCCCCCCCCCCCC | 18.38 | - | |
46 | Phosphorylation | TMSQSTQTNEFLSPE CCCCCCCCCCCCCHH | 36.48 | - | |
51 | Phosphorylation | TQTNEFLSPEVFQHI CCCCCCCCHHHHHHH | 25.08 | - | |
66 (in isoform 2) | Phosphorylation | - | 2.46 | - | |
68 (in isoform 2) | Phosphorylation | - | 25.22 | - | |
149 | Phosphorylation | SVTAPSPYAQPSSTF CCCCCCCCCCCCCCC | 23.39 | 22817900 | |
160 | Phosphorylation | SSTFDALSPSPAIPS CCCCCCCCCCCCCCC | 25.67 | - | |
162 | Phosphorylation | TFDALSPSPAIPSNT CCCCCCCCCCCCCCC | 24.48 | - | |
171 | Phosphorylation | AIPSNTDYPGPHSFD CCCCCCCCCCCCCEE | 14.19 | 22817900 | |
202 | Phosphorylation | STELKKLYCQIAKTC EHHHHHHHHHHHCCC | 7.38 | 29496907 | |
231 | Phosphorylation | VIRAMPVYKKAEHVT EEEEEECCCCCHHHH | 10.82 | - | |
232 | Acetylation | IRAMPVYKKAEHVTE EEEEECCCCCHHHHH | 45.82 | 82517801 | |
242 | Methylation | EHVTEVVKRCPNHEL HHHHHHHHHCCCCHH | 54.16 | - | |
281 | Phosphorylation | QYVEDPITGRQSVLV EEEECCCCCCEEEEE | 31.53 | - | |
290 | Phosphorylation | RQSVLVPYEPPQVGT CEEEEEECCCCCCCC | 33.32 | 22817900 | |
326 | Phosphorylation | RPILIIVTLETRDGQ CCEEEEEEEECCCCC | 14.41 | 19413330 | |
329 | Phosphorylation | LIIVTLETRDGQVLG EEEEEEECCCCCEEC | 36.85 | 19413330 | |
358 | Phosphorylation | DRKADEDSIRKQQVS CCCCCHHHHHHHHCC | 23.42 | - | |
365 | Phosphorylation | SIRKQQVSDSTKNGD HHHHHHCCCCCCCCC | 22.85 | 24043423 | |
367 | Phosphorylation | RKQQVSDSTKNGDGT HHHHCCCCCCCCCCC | 33.50 | 24043423 | |
368 | Phosphorylation | KQQVSDSTKNGDGTK HHHCCCCCCCCCCCC | 33.25 | 24043423 | |
374 | Phosphorylation | STKNGDGTKRPFRQN CCCCCCCCCCCCCCC | 28.72 | 30631047 | |
388 | Phosphorylation | NTHGIQMTSIKKRRS CCCCCCCCCEEECCC | 15.78 | 27080861 | |
389 | Phosphorylation | THGIQMTSIKKRRSP CCCCCCCCEEECCCC | 27.37 | 27080861 | |
395 | Phosphorylation | TSIKKRRSPDDELLY CCEEECCCCCCCCEE | 36.39 | 25106551 | |
397 (in isoform 8) | Phosphorylation | - | 64.36 | 27067055 | |
402 | Phosphorylation | SPDDELLYLPVRGRE CCCCCCEEEECCCHH | 22.91 | 27642862 | |
431 | Phosphorylation | MQYLPQHTIETYRQQ HHHCCHHHHHHHHHH | 18.43 | 28450419 | |
434 | Phosphorylation | LPQHTIETYRQQQQQ CCHHHHHHHHHHHHH | 21.83 | 28450419 | |
435 | Phosphorylation | PQHTIETYRQQQQQQ CHHHHHHHHHHHHHH | 8.14 | 28450419 | |
451 | Phosphorylation | QHLLQKQTSIQSPSS HHHHHHHHHCCCCCC | 34.53 | 25106551 | |
452 | Phosphorylation | HLLQKQTSIQSPSSY HHHHHHHHCCCCCCC | 19.01 | 25106551 | |
455 | Phosphorylation | QKQTSIQSPSSYGNS HHHHHCCCCCCCCCC | 25.69 | 23927012 | |
457 | Phosphorylation | QTSIQSPSSYGNSSP HHHCCCCCCCCCCCC | 41.25 | 23927012 | |
458 | Phosphorylation | TSIQSPSSYGNSSPP HHCCCCCCCCCCCCC | 40.21 | 25106551 | |
459 | Phosphorylation | SIQSPSSYGNSSPPL HCCCCCCCCCCCCCH | 25.35 | 25106551 | |
462 | Phosphorylation | SPSSYGNSSPPLNKM CCCCCCCCCCCHHHC | 39.60 | 23927012 | |
463 | Phosphorylation | PSSYGNSSPPLNKMN CCCCCCCCCCHHHCC | 34.24 | 28731282 | |
477 | Phosphorylation | NSMNKLPSVSQLINP CCCCCCCCHHHHCCH | 44.85 | 19282665 | |
479 | Phosphorylation | MNKLPSVSQLINPQQ CCCCCCHHHHCCHHH | 24.49 | 22817900 | |
491 | Phosphorylation | PQQRNALTPTTIPDG HHHCCCCCCCCCCCC | 19.04 | 19282665 | |
491 (in isoform 7) | Phosphorylation | - | 19.04 | 27067055 | |
551 | Phosphorylation | PTDCSIVSFLARLGC CCCCHHHHHHHHCCC | 16.93 | 24719451 | |
560 | Phosphorylation | LARLGCSSCLDYFTT HHHCCCCHHHHHHHC | 23.83 | 22817900 | |
588 | Sumoylation | MDDLASLKIPEQFRH HHHHHHCCCCHHHHH | 54.44 | - | |
588 | Sumoylation | MDDLASLKIPEQFRH HHHHHHCCCCHHHHH | 54.44 | - | |
599 | Ubiquitination | QFRHAIWKGILDHRQ HHHHHHHHHHCCHHH | 29.93 | - | |
611 | Phosphorylation | HRQLHEFSSPSHLLR HHHHHCCCCHHHHCC | 38.05 | 23927012 | |
612 | Phosphorylation | RQLHEFSSPSHLLRT HHHHCCCCHHHHCCC | 35.42 | 25394399 | |
614 | Phosphorylation | LHEFSSPSHLLRTPS HHCCCCHHHHCCCCC | 28.81 | 27080861 | |
619 | Phosphorylation | SPSHLLRTPSSASTV CHHHHCCCCCCCCEE | 27.73 | 27794612 | |
621 | Phosphorylation | SHLLRTPSSASTVSV HHHCCCCCCCCEEEC | 37.61 | 25394399 | |
622 | Phosphorylation | HLLRTPSSASTVSVG HHCCCCCCCCEEECC | 27.69 | 25394399 | |
624 | Phosphorylation | LRTPSSASTVSVGSS CCCCCCCCEEECCCC | 31.15 | 27794612 | |
625 | Phosphorylation | RTPSSASTVSVGSSE CCCCCCCEEECCCCC | 19.27 | 27794612 | |
627 | Phosphorylation | PSSASTVSVGSSETR CCCCCEEECCCCCCC | 22.35 | 27067055 | |
645 | Phosphorylation | VIDAVRFTLRQTISF HHHHHHEEEEECCCC | 15.51 | 24719451 | |
651 | Phosphorylation | FTLRQTISFPPRDEW EEEEECCCCCCCCCC | 34.78 | 24719451 | |
676 | Sumoylation | RNKQQRIKEEGE--- HHHHHHHHHCCC--- | 52.48 | - | |
676 | Sumoylation | RNKQQRIKEEGE--- HHHHHHHHHCCC--- | 52.48 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
43 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
46 | T | Phosphorylation | Kinase | GAK | O14976 | PSP |
51 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
66 | S | Phosphorylation | Kinase | TGFBR1 | P36897 | PSP |
66 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
68 | S | Phosphorylation | Kinase | TGFBR1 | P36897 | PSP |
68 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
149 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
171 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
281 | T | Phosphorylation | Kinase | GAK | O14976 | PSP |
290 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
301 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
361 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
385 | S | Phosphorylation | Kinase | ATM | Q13315 | GPS |
397 | T | Phosphorylation | Kinase | CDK2 | P24941 | GPS |
466 | S | Phosphorylation | Kinase | P70-SUBFAMILY | - | GPS |
479 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
491 | T | Phosphorylation | Kinase | HIPK2 | Q9H2X6 | PSP |
491 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
560 | S | Phosphorylation | Kinase | RPS6KB1 | P23443 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | RCHY1 | Q96PM5 | PMID:23235527 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW7 | Q969H0 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP1 | Q9H0M0 | PMID:18806757 |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:16861923 |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4L | Q96PU5 | PMID:16908849 |
- | K | Ubiquitination | E3 ubiquitin ligase | CRBN | Q96SW2 | PMID:31591562 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of P63_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of P63_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
103285 | Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) | |||||
106260 | Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) | |||||
604292 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) | |||||
605289 | Split-hand/foot malformation 4 (SHFM4) | |||||
603543 | Limb-mammary syndrome (LMS) | |||||
Note=Defects in TP63 are a cause of cervical, colon, head and neck, lung and ovarian cancers. | ||||||
129400 | ||||||
129400 | Non-syndromic orofacial cleft 8 (OFC8) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...